{
  "item1": "purchase products directly manufacturers wholesalers/distributors. They then sell them consumers relatively small quantities personal use. Institutional pharmacies address unique needs hospitals, nursing homes other such venues. Among services provided specialized packaging, including injectables unit-dose products, controlled administration.",
  "item7": "Emerging Markets Segment Net sales Emerging Markets decreased $300.9 million 12% year ended December 31, 2024 when compared prior year. Net sales decreased approximately $294.6 million, 12%, due inclusion net sales prior year period related divestitures closed during 2023 2024. decrease net sales also partially driven unfavorable impact foreign currency translation approximately $116.2 million, 5%. Constant currency net sales remaining business increased approximately $109.9 million, 4%, when compared prior year, primarily driven new products higher net sales existing products certain Latin American, Middle Eastern Asian countries.",
  "item2": "ITEM 2. MANAGEMENT’S DISCUSSION ANALYSIS FINANCIAL CONDITION RESULTS OPERATIONS following discussion analysis addresses material changes financial condition results operations Viatris Inc. subsidiaries periods presented. Unless context requires otherwise, “Company,” “Viatris,” “our” “we” refer Viatris Inc."
}